Angus Russell, chief executive of the speciality pharmaceutical firm Shire, has taken advantage of a strong performance from the group recently to sell a big chunk of shares.
He offloaded 17,219 at 1,029p each, or a total of about £177,000.
Following the sale Russell now has 96,331 shares in the group as well as various options and other rights.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Shares in Shire have rallied strongly in the past couple of months.
The company received a boost on Tuesday when it said data from the final two Phase III trials for its Gaucher disease treatment velaglucerase alfa met expectations.
Top Director Buys
Value: £75,200
Value: $68,000
Value: £44,183
Value: £15,610
Top Director Sells
Value: £952,400
Value: £524,097
Value: £191,350
Value: £177,184
Value: £13,022
-
What happens if you can’t pay your tax bill, and what is "Time to Pay"?Millions are due to file their tax return this Friday as the self-assessment deadline closes. Though the nightmare is not over until you pay the taxman what you owe - or face a penalty. But what happens if you can't afford to pay HMRC your tax bill, and what is "Time to Pay"?
-
What does Rachel Reeves’s plan for growth mean for UK investors?Rachel Reeves says she is going “further and faster” to kickstart the UK economy, but investors are unlikely to be persuaded
